Food News and Research

RSS

Lessons learned from troubles with COX-2 inhibitors

One of the nation’s leading cardiovascular medical researchers has issued a call for less aggressive direct-to-consumer advertising and better safety assurances of medications in a special article posted online by JAMA because of its relevance to the recent withdrawals and warning labels on the pain-relieving drugs known as COX-2 inhibitors.

28 Dec 2004

PAHO urges donors to wait for assessment of Asian tragedy's needs

The Pan American Health Organization (PAHO) is urging all citizens, organizations and governments wishing to help the tsunami victims in southern and Southeast Asia to wait for an assessment of what's needed before sending anything.

28 Dec 2004

Red Cross Red Crescent launches appeal for victims of the Bay of Bengal earthquake and tsunamis

The International Federation of Red Cross and Red Crescent Societies has launched a preliminary appeal for 7.5 million Swiss francs to assist some 500,000 people and bring immediate support to relief operations of Red Cross and Red Crescent Societies in Sri Lanka, India, Indonesia, Malaysia, Thailand and other countries in the region after the strongest earthquake in 40 years caused massive tidal waves

27 Dec 2004

CARE Australia launches Tsunami emergency appeal

CARE Australia has launched an emergency appeal to provide lifesaving assistance to the survivors of yesterday’s devastating southern Asia earthquake.

27 Dec 2004

World Vision launches response to Tsunami devastation

World Vision relief teams in Asia are dispatching emergency supplies -- blankets, water, medicines and tents -- to thousands of people left homeless by Sunday's tsunamis devastating coastlines for between Indonesia and East Africa.

27 Dec 2004

FDA go ahead for first of kind genetic lab test

The U.S. Food and Drug Administration (FDA) has approved the marketing of the first laboratory test system that will allow physicians to consider unique genetic information from patients in selecting medications and doses of medications for a wide variety of common conditions such as cardiac disease, psychiatric disease, and cancer.

27 Dec 2004

World Health Organization's new global report on iodine deficiency

The number of countries where iodine deficiency is a public health problem has halved over the past decade, says the World Health Organization (WHO) in a new global report on iodine status.

26 Dec 2004

New gel promotes healing by gluing bone pieces together

A new material that fuses biological and synthetic substances at the molecular level speeds bone and cartilage repair. Its creators at the Technion-Israel Institute of Technology say laboratory studies have shown the new gel promotes healing by gluing bone pieces together and stimulating tissue development.

26 Dec 2004

FDA issues not approvable letter to Cellegy Pharmaceuticals

Cellegy Pharmaceuticals has announced receipt of a communication from the U.S. Food and Drug Administration in the form of a Not Approvable Letter for its product Cellegesic(TM) (nitroglycerin ointment).

26 Dec 2004

Seafood research will bring healthier lifestyle

The biggest research project ever sponsored by the EU in the seafood sector will help to meet the consumer demand for more healthy products.

23 Dec 2004

Stevioside is an excellent choice for diabetics

Stevioside, the main sweet component in the leaves of the Stevia plant, tastes about 300 times sweeter than table sugar, which means only a small amount is needed for sweetening purposes.

23 Dec 2004

Public health advisory for the use of non-steroidal anti-inflammatory drug products

The Food and Drug Administration (FDA) has issued a Public Health Advisory summarizing the agency's recent recommendations concerning the use of non-steroidal anti-inflammatory drug products (NSAIDs), including those known as COX-2 selective agents.

23 Dec 2004

Bacteria can use a sonar-like system to spot other cells

For the first time, scientists have found that bacteria can use a Sonar-like system to spot other cells (either normal body cells or other bacteria) and target them for destruction.

23 Dec 2004

Evidence suggests that changes in the bacteria and fungi in the gastrointestinal tract can intensify the immune system's reaction to common allergens

If you want to avoid allergies or asthma, scientists at the University of Michigan Medical School suggest you start paying more attention to what's in your gut.

23 Dec 2004

FDA approves Enablex for the treatment of overactive bladder

Novartis Pharmaceuticals Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved Enablex® (darifenacin) extended-release tablets (7.5mg and 15mg) for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency and frequency.

22 Dec 2004

No increased cardiovascular risk seen in elderly patients taking Celebrex

The National Institutes of Health has reported in an Alzheimer's Disease prevention study that there was no increased cardiovascular risk seen in elderly patients taking Celebrex (400 mg daily) for up to three years.

21 Dec 2004

20 new policies adopted by American Public Health Association

The American Public Health Association recently adopted 20 policies addressing a broad range of issues in public health from underage alcohol consumption and nutrition labeling in restaurants to the supply of flu vaccinations and threats to immigrants’ health care.

21 Dec 2004

Brisk walks substantially improve blood vessel function both before and during the hours after eating a fatty meal

A 90-minute walk lowered triglycerides and improved blood vessel function in a small group of lean and obese men, and the benefits persisted into the following day, even after participants ate a fatty meal, according to a new study in the Dec. 21, 2004 issue of the Journal of the American College of Cardiology.

21 Dec 2004

Dramatic changes in the way the FDA address patient safety are needed

Food and Drug Administration policies prevent pharmaceutical manufacturers from informing patients about potentially fatal toxicities that occur with some cancer drugs -- policies that should be revised immediately, according to Northwestern University researchers.

20 Dec 2004

FDA issues advice on Naproxen

The FDA has released the following statement on NIH halting a clinical trial involving non-steroidal anti-inflammatory drugs in patients at risk of developing Alzheimer's Disease:

20 Dec 2004